Product
TKI in CML
1 clinical trial
2 indications
Indication
Tyrosine Kinase InhibitorsIndication
Chronic Myeloid LeukemiaClinical trial
Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic StrategiesStatus: Recruiting, Estimated PCD: 2028-12-01